The tissue inhibitors of metalloproteinases (TIMPs) play a crucial role in the physiological turnover of the extracellular matrix (ECM) by tightly regulating matrix metalloproteinase (MMP) activities. Disturbances in the TIMP/MMP system have been implicated in many disease processes where loss of ECM integrity is a principal feature. More recently, we have shown that mutations in TIMP3 cause the autosomal dominant disorder Sorsby's fundus dystrophy (SFD). This is a macular degeneration disorder with characteristic ECM irregularities in Bruch's membrane. To further facilitate mutational analysis and to provide a basis for functional studies, we now report the genomic organization of the human TIMP3 gene
Tissue Inhibitor of metalloproteinases-3 (TIMP-3) is a potent matrix-bound angiogenesis inhibitor. M...
The matrix metalloproteinases (MMPs) play a key role in the normal physiology of connective tissue d...
Sorsby fundus dystrophy (SFD) is a macular degeneration caused by mutations in TIMP3, the majority o...
The tissue inhibitors of metalloproteinases (TIMPs) play a crucial role in the physiological turnove...
A transient COS-7 cell expression system was used to investigate the functional domain arrangement ...
Purpose. Mutations in the gene encoding the tissue inhibitor of metalloproteinases-3 (TIMP3) have ...
The tissue inhibitor of metalloproteinases-3 (TIMP3) is a multifunctional protein tightly associated...
The tissue inhibitor of metalloproteinases-3 (TIMP3) is a multifunctional protein tightly associated...
Sorsby’s fundus dystrophy (SFD) is a dominantly inherited degenerative disease of the retina that l...
AbstractTissue inhibitors of metalloproteinases (TIMPs) are widely distributed in the animal kingdom...
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a matrix-bound inhibitor of matrix metalloprote...
The hereditary macular dystrophies are progressive degenerations of the central retina and contribut...
Sorsby fundus dystrophy (SFD) is an autosomal dominant macular degeneration of late onset. A key fea...
The proteolytical cleavage of transmembrane proteins with subsequent release of their extracellular ...
PURPOSE: To assess the expression of MMP (matrix metalloproteinase)-2 and -9 and TIMP (tissue inhibi...
Tissue Inhibitor of metalloproteinases-3 (TIMP-3) is a potent matrix-bound angiogenesis inhibitor. M...
The matrix metalloproteinases (MMPs) play a key role in the normal physiology of connective tissue d...
Sorsby fundus dystrophy (SFD) is a macular degeneration caused by mutations in TIMP3, the majority o...
The tissue inhibitors of metalloproteinases (TIMPs) play a crucial role in the physiological turnove...
A transient COS-7 cell expression system was used to investigate the functional domain arrangement ...
Purpose. Mutations in the gene encoding the tissue inhibitor of metalloproteinases-3 (TIMP3) have ...
The tissue inhibitor of metalloproteinases-3 (TIMP3) is a multifunctional protein tightly associated...
The tissue inhibitor of metalloproteinases-3 (TIMP3) is a multifunctional protein tightly associated...
Sorsby’s fundus dystrophy (SFD) is a dominantly inherited degenerative disease of the retina that l...
AbstractTissue inhibitors of metalloproteinases (TIMPs) are widely distributed in the animal kingdom...
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a matrix-bound inhibitor of matrix metalloprote...
The hereditary macular dystrophies are progressive degenerations of the central retina and contribut...
Sorsby fundus dystrophy (SFD) is an autosomal dominant macular degeneration of late onset. A key fea...
The proteolytical cleavage of transmembrane proteins with subsequent release of their extracellular ...
PURPOSE: To assess the expression of MMP (matrix metalloproteinase)-2 and -9 and TIMP (tissue inhibi...
Tissue Inhibitor of metalloproteinases-3 (TIMP-3) is a potent matrix-bound angiogenesis inhibitor. M...
The matrix metalloproteinases (MMPs) play a key role in the normal physiology of connective tissue d...
Sorsby fundus dystrophy (SFD) is a macular degeneration caused by mutations in TIMP3, the majority o...